The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice

Expert Review of Respiratory Medicine

Volumn 8, Issue 4, 2014, Pages 479-491

  Van Der Molen, Thys ^a   Diamant, Zuzana ^a,b   Kocks, Jan Willem H ^a   Tsiligianni, Ioanna G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CAT; CCQ; COPD; Health status; Management; Questionnaires

Indexed keywords

ANAMNESIS; ANXIETY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL COPD QUESTIONNAIRE; CLINICAL PRACTICE; COPD ASSESSMENT TEST; COST OF ILLNESS; DEPRESSION; DISCRIMINANT VALIDITY; HEALTH STATUS; HUMAN; INTERNAL CONSISTENCY; MORTALITY; PATIENT PREFERENCE; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PSYCHOMETRY; PULMONARY REHABILITATION; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SMOKING CESSATION; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TEST RETEST RELIABILITY; DISEASE MANAGEMENT; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

DISEASE MANAGEMENT; HEALTH STATUS; HUMANS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84904330615     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2014.918851     Document Type: Review

References (94)

1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. Available from: www.goldcopd.org [Last accessed February 2014]
2. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64(10): 863-8
3. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61(12): 1043-7
4. Price D, Freeman D, Cleland J, et al. Earlier diagnosis and earlier treatment of COPD in primary care. Prim Care Respir J 2011;20(1): 15-22
5. Bertella E, Zadra A, Vitacca M; on behalf of General Practitioners Distretto 04 ASL 02 Brescia, Italy. COPD management in primary care: is an educational plan for GPs useful? Multidiscip Respir Med 2013;8(1): 24
6. Zoia MC, Corsico AG, Beccaria M, et al. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med 2005; 99(12): 1568-75
7. Bastin AJ, Starling L, Ahmed R, et al. High prevalence of undiagnosed and severe chronic obstructive pulmonary disease at first hospital admission with acute exacerbation. Chron Respir Dis 2010;7(2): 91-7
8. Albers M, Schermer T, Molema J, et al. Do family physicians' records fit guideline diagnosed COPD? Fam Pract 2009;26(2): 81-7
9. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163(5): 1256-76
10. Westwood M, Bourbeau J, Jones PW, et al. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res 2011;12: 40
11. Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J 2011;20(3): 257-68 •• A meta-analysis showing that forced expiratory volume in 1 s has weak to modest correlations with almost all health status questionnaires, while other factors such as dyspnea, depression, anxiety and exercise tolerance have the strongest ones.
12. Agusti A, Calverley PM, Celli B, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11: 122
13. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J 2013;22(1): 117-21
14. Calverley PM, Anderson JA, Celli B, et al. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356: 8): 775-89
15. Jones PW, Anderson JA, Calverley PM, et al. TORCH investigators. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res 2011;12: 71
16. Spencer S, Calverley PM, Sherwood Burge P, Jones PW; ISOLDE Study Group. Inhaled steroids in obstructive lung disease. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163(1): 122-8
17. Tashkin DP, Celli B, Senn S, et al. UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359(15): 1543-54
18. Rabe KF, Wedzicha JA. Controversies in treatment of chronic obstructive pulmonary disease. Lancet 2011;378(9795): 1038-47
19. Postma D, Anzueto A, Calverley P, et al. A new perspective on optimal care for patients with COPD. Prim Care Respir J 2011;20(2): 205-9
20. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34(3): 648-54 •• The study presents issues regarding the development and first validation of the chronic obstructive pulmonary disease (COPD) Assessment Test (CAT).
21. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1: 13 •• The study presents issues regarding the development, validity and responsiveness of the Clinical COPD Questionnaire (CCQ).
22. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7): 581-6
23. Levy ML, Quanjer PH, Booker R, et al. General Practice Airways Group. Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1 www.gpiag.org 2 www.artp.org 3 www. educationforhealth.org.uk. Prim Care Respir J 2009.18(3): 130-47
24. Kocks JW, Kerstjens HA, Snijders SL, et al. Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes 2010;8: 135 • The study assessed the validity of the CCQ by different methods on the individual patient level.
25. Jahagirdar D, Kroll T, Ritchie K, Wyke S. Using patient reported outcome measures in health services: a qualitative study on including people with low literacy skills and learning disabilities. BMC Health Serv Res 2012;12: 431
26. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med 2005;60(4): 833-43
27. Miravitlles M, Ferrer J, Baró E, et al. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med 2013; 107(12): 1977-85
28. Wortz K, Cade A, Menard JR, et al. A qualitative study of patients' goals and expectations for self-management of COPD. Prim Care Respir J 2012;21(4): 384-91
29. Yen L, Gillespie J, Rn YH, et al. Health professionals, patients and chronic illness policy: a qualitative study. Health Expect 2011;14(1): 10-20
30. Boeckxstaens P, Deregt M, Vandesype P, et al. Chronic obstructive pulmonary disease and comorbidities through the eyes of the patient. Chron Respir Dis 2012;9(3): 183-91
31. Devlin NJ, Appleby J. Getting the most out of PROMS: putting health outcomes at the heart of NHS decision-making, The King's fund. 2010. Available from: www.kingsfund. org.uk/publications/getting-most-out-proms [Last accessed February 2014]
32. Janson C, Marks G, Buist S, et al. The impact of COPD on health status: findings from the BOLD study. Eur Respir J 2013; 42(6): 1472-83
33. Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003;21(2): 267-72
34. Hareendran A, Palsgrove AC, Mocarski M, et al. The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease. Health Qual Life Outcomes 2013;11: 104
35. Skilbeck J, Mott L, Smith D, et al. Nursing care for people dying from chronic obstructive airways disease. Int J Palliat Nurs 1997;3: 100-6
36. Ring L, Danielsson E. Patientś experiences of long-term oxygen therapy. J Adv Nurs 1997;26: 337-44
37. Elofsson LC, Ohlén J. Meanings of being old and living with chronic obstructive pulmonary disease. Palliat Med 2004;18(7): 611-18
38. Kühl K, Schürmann W, Rief W. Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis 2008;3(4): 727-36
39. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20(4): 799-805
40. Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006;130: 1129-37
41. Tashkin DP, Rennard S, Taylor Hays J, et al. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respir Med 2011;105(11): 1682-90
42. Kocks J, de Jong C, Berger MY, et al. Putting health status guided COPD management to the test: protocol of the MARCH study. BMC Pulm Med 2013;13: 41
43. Measuring success in the NHS. Using patient-assessed health outcomes to manage the performance of healthcare providers. Available from: www.staff.city.ac.uk/n.j. devlin/measuring%20success%20in%20the% 20NHS.pdf [Last accessed February 2014]
44. Cave AJ, Atkinson L, Tsiligianni IG, Kaplan AG. Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int J Chron Obstruct Pulmon Dis 2012;7: 447-56 •• The study presents a guide developed by the International Primary Care Respiratory Group to assess different COPD wellness tools for use in primary care.
45. Cave AJ, Tsiligianni I, Chavannes N, et al. IPCRG Users' Guide to COPD "Wellness" Tools. Westhill: IPCRG; 2010 September. Available from: www.theipcrg.org/resources/ipcrg-users-guide-to-copd-wellness-tools. pdf [Last accessed February 2014]
46. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med 1991;85(Suppl B): 25-31.discussion 33-7
47. Haughney J, Gruffydd-Jones K. Patient-centered outcomes in primary care management of COPD - what do recent clinical trial data tell us? Prim Care Respir J 2004;13(4): 185-97
48. Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med 2006; 119(10 Suppl 1): 12-20
49. Leivseth L, Brumpton BM, Nilsen TI, et al. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway. Thorax 2013; 68(10): 914-21
50. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186(10): 975-81
51. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest 2013;143(3): 694-702
52. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1: 43-50
53. Agusti A, Edwards L, Celli B, et al. Characteristics, stability and outcomes of the GOLD 2011 COPD groups in the ECLIPSE cohort. Eur Respir J 2013;42(3): 636-46
54. Papadopoulos G, Vardavas CI, Limperi M, et al. Smoking cessation can improve quality of life among COPD patients: validation of the clinical COPD questionnaire into Greek. BMC Pulm Med 2011;11: 13
55. Damato S, Bonatti C, Frigo V, et al. Validation of the Clinical COPD questionnaire in Italian language. Health Qual Life Outcomes 2005;3(1): 9
56. Tsiligianni IG, van der Molen T, Moraitaki D, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012;12: 20 •• Among the few studies using quantitative and qualitative data to perform a head-to-head comparison of the CAT with the CCQ and the St George Respiratory Questionnaire.
57. Reda AA, Kotz D, Kocks JW, et al. Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. Respir Med 2010; 104(11): 1675-82
58. Antoniu SA, Puiu A, Zaharia B, Azoicai D. Health status during hospitalisations for chronic obstructive pulmonary disease exacerbations: the validity of the Clinical COPD Questionnaire. Expert Rev Pharmacoecon Outcomes Res 2014;14(2): 283-7
59. Ställberg B, Nokela M, Ehrs PO, et al. Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes 2009;7: 26
60. Agustí A, Soler JJ, Molina J, et al. Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations? COPD 2012;9(5): 492-8
61. Hwang YI, Jung KS, Lim SY, et al. A validation study for the Korean version of chronic obstructive pulmonary disease assessment test (CAT). Tuberc Respir Dis (Seoul) 2013;74(6): 256-63
62. da Silva GP, Morano MT, Viana CM, et al. Portuguese-language version of the COPD Assessment Test: validation for use in Brazil. J Bras Pneumol 2013;39(4): 402-8
63. Tsuda T, Suematsu R, Kamohara K, et al. Development of the Japanese version of the COPD Assessment Test. Respir Investig 2012;50(2): 34-9
64. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD 2012;9(1): 12-15
65. Kwon N, Amin M, Hui DS, et al. Validity of the COPD assessment test translated into local languages for Asian patients. Chest 2013;143(3): 703-10
66. Kon SS, Clark AL, Dilaver D, et al. Response of the COPD Assessment Test to pulmonary rehabilitation in unselected chronic respiratory disease. Respirology 2013;18(6): 974-7
67. Jones PW, Harding G, Wiklund I, et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest 2012; 142(1): 134-40
68. Miyazaki M, Nakamura H, Chubachi S, et al. Keio COPD Comorbidity Research (K-CCR) Group. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res 2014;15(1): 13
69. Horita N, Yomota M, Sasaki M, et al. Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients. Clin Respir J 2014; 8(2): 213-19
70. Liu SF, Tseng CW, Tu ML, et al. The clinical COPD questionnaire correlated with BODE index-A cross-sectional study. Scientific World Journal 2012;2012: 361535
71. de-Torres JP, Marin JM, Martinez-Gonzalez C, et al. for the COPD History Assessment In SpaiN (CHAIN) cohort. Clinical Application of the COPD Assessment Test: Longitudinal Data from the CHAIN Cohort. Chest 2014. [Epub ahead of print]
72. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011;38(1): 29-35
73. Kon SS, Dilaver D, Mittal M, et al. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax 2013. [Epub ahead of print]
74. Kocks JW, van den Berg JW, Kerstjens HA, et al. Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013;8: 273-86
75. Trappenburg JC, Touwen I, de Weert-van Oene GH, et al. Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes 2010;8: 102
76. Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011;66(5): 425-9
77. Dodd JW, Marns PL, Clark AL, et al. The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD 2012;9(4): 390-4
78. Varol Y, Ozacar R, Balci G, et al. Assessing the Effectiveness of the COPD Assessment Test (CAT) to Evaluate COPD Severity and Exacerbation Rates. COPD 2014;11(2): 221-5
79. Miravitlles M, García-Sidro P, Fernández-Nistal A, et al. Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes 2013;11: 147
80. Lee SD, Huang MS, Kang J, et al. Investigators of the Predictive Ability of CAT in Acute Exacerbations of COPD (PACE) Study. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med 2014;108(4): 600-8
81. Mackay AJ, Donaldson GC, Patel AR, et al. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012;185(11): 1218-24
82. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10(4): 407-15
83. Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006;7: 62
84. Jones PW. COPD assessment test rationale, development, validation and performance. COPD 2013;10(2): 269-71
85. Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011;6: 289-96
86. Jones PW. Response to: Responsiveness of the COPD Assessment Test: The minimal clinically important difference does matter (in response to Kocks et al Chest 2012; 142; 267-8). Chest 2012;142(1): 268-9
87. Clinical COPD questionnaire. Available from: www.ccq.nl
88. COPD assessment test. Available from: www.catestonline.org
89. da Silva GF, Morano MT, Sales MP, et al. Comparison of face-to-face interview and telephone interview administration of COPD assessment test: a randomized study. Qual Life Res 2014;23(4): 1193-7
90. Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract 2007;24(3): 217-23
91. Sundh J, Ställberg B, Lisspers K, et al. Comorbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD 2011;8(3): 173-81
92. Hilmarsen CW, Wilke S, Engan H, et al. Impact of symptoms of anxiety and depression on COPD Assessment Test (CAT) scores. Eur Respir J 2014;43(3): 898-900
93. Lee YS, Park S, Oh YM, Lee SD, et al. Korean COPD Study Group. Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study. J Korean Med Sci 2013; 28(7): 1048-54
94. Sundh J, Janson C, Lisspers K, et al. Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis 2012;7: 833-42